How Much Do Focal Infarcts Distort White Matter Lesions and Global Cerebral Atrophy Measures?
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background: White matter lesions (WML) and brain atrophy are important biomarkers in stroke and dementia. Stroke lesions, either acute or old, symptomatic or silent, are common in older people. Such stroke lesions can have similar signals to WML and cerebrospinal fluid (CSF) on magnetic resonance (MR) images, and may be classified accidentally as WML or CSF by MR image processing algorithms, distorting WML and brain atrophy volume from the true volume. We evaluated the effect that acute or old stroke lesions at baseline, and new stroke lesions occurring during follow-up, could have on measurement of WML volume, cerebral atrophy and their longitudinal progression. Methods: We used MR imaging data from patients who had originally presented with acute lacunar or minor cortical ischaemic stroke symptoms, recruited prospectively, who were scanned at baseline and about 3 years later. We measured WML and CSF volumes (ml) semi-automatically. We manually outlined the acute index stroke lesion (ISL), any old stroke lesions present at baseline, and new lesions appearing de novo during follow-up. We compared baseline and follow-up WML volume, cerebral atrophy and their longitudinal progression excluding and including the acute ISL, old and de novo stroke lesions. A non-parametric test (Wilcoxon’s signed rank test) was used to compare the effects. Results: Among 46 patients (mean age 72 years), 33 had an ISL visible on MR imaging (median volume 2.05 ml, IQR 0.88–8.88) and 7 of the 33 had old lacunes at baseline: WML volume was 8.54 ml (IQR 5.86–15.80) excluding versus 10.98 ml (IQR 6.91–24.86) including ISL (p < 0.001). At follow-up, median 39 months later (IQR 30–45), 3 patients had a de novo stroke lesion; total stroke lesion volume had decreased in 11 and increased in 22 patients: WML volume was 12.17 ml (IQR 8.54–19.86) excluding versus 14.79 ml (IQR 10.02–38.03) including total stroke lesions (p < 0.001). Including/excluding lacunes at baseline or follow-up also made small differences. Twenty-two of the 33 patients had tissue loss due to stroke lesions between baseline and follow-up, resulting in a net median brain tissue volume loss (i.e. atrophy) during follow-up of 24.49 ml (IQR 12.87–54.01) excluding versus 24.61 ml (IQR 15.54–54.04) including tissue loss due to stroke lesions (p < 0.001). Including stroke lesions in the WML volume added substantial noise, reduced statistical power, and thus increased sample size estimated for a clinical trial. Conclusions: Failure to exclude even small stroke lesions distorts WML volume, cerebral atrophy and their longitudinal progression measurements. This has important implications for design and sample size calculations for observational studies and randomised trials using WML volume, WML progression or brain atrophy as outcome measures. Improved methods of discriminating between stroke lesions and WML, and between tissue loss due to stroke lesions and true brain atrophy are required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Known examples to avoid are the misclassification of white matter hyperintensities as normal grey matter, of lacunes as ventricle or white matter hyperintensity, or of small subcortical infarcts as white matter hyperintensities.84”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [84]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GPOWER: A general power analysis program
Erdfelder, E., Faul, F., & Buchner, A. (1996) · Behavior Research Methods, Instruments, & Computers · doi:10.3758/bf03203630 · Cited by 4,864 · cited 1×
“G * Power 3 was used for sample size calculations [13] .”
MethodGorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Debette, S., & Markus, H. S. (2010) · BMJ · doi:10.1136/bmj.c3666 · Cited by 2,328 · cited 1×
“White matter lesions (WML) are common in older people and in patients with stroke [1] and are associated with cognitive impairment and dementia, particularly in those with WML progression [2–4] .”
Background(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Silent brain infarcts: a systematic review
Vermeer, S. E., Longstreth, W. T., & Koudstaal, P. J. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70170-9 · Cited by 1,221 · cited 1×
“Cerebral infarcts, cortical or subcortical, symptomatic or silent [5] occur in approximately one-third to one half of older people on scanning, indicating that silent lesions are more frequent than clinically evident stroke [6] .”
BackgroundIncidental findings on brain magnetic resonance imaging: systematic review and meta-analysis
Morris, Z., Whiteley, W. N., Longstreth, W. T., Weber, F., Lee, Y.-C., Tsushima, Y., Alphs, H., Ladd, S. C., Warlow, C., Wardlaw, J. M., et al. (2009) · BMJ · doi:10.1136/bmj.b3016 · Cited by 792 · cited 1×
“Our population had more stroke lesions than in similarly aged subjects without a history of stroke, although silent cortical and subcortical stroke lesions and lacunes occur in up to 75% of otherwise asymptomatic older volunteers [6, 16, 17] .”
BackgroundSelf-citationLongstreth, W. T., Arnold, A. M., Beauchamp, N. J., Manolio, T. A., Lefkowitz, D., Jungreis, C., Hirsch, C. H., O’Leary, D. H., & Furberg, C. D. (2005) · Stroke · doi:10.1161/01.str.0000149625.99732.69 · Cited by 474
Imaging cerebral atrophy: normal ageing to Alzheimer's disease
Fox, N. C., & Schott, J. M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15441-x · Cited by 436 · cited 1×
“[7–9] .”
Schmidt, R., Ropele, S., Enzinger, C., Petrovic, K., Smith, S., Schmidt, H., Matthews, P. M., & Fazekas, F. (2005) · Annals of Neurology · doi:10.1002/ana.20630 · Cited by 408
Lacunar stroke is associated with diffuse blood-brain barrier dysfunction
Wardlaw, J. M., Doubal, F., Armitage, P., Chappell, F., Carpenter, T., Muñoz Maniega, S., Farrall, A., Sudlow, C., Dennis, M., & Dhillon, B. (2009) · Annals of Neurology · doi:10.1002/ana.21549 · Cited by 364 · cited 3×
“In this fairly typical cohort of patients who had originally presented with an acute lacunar or cortical mild stroke [11] , we demonstrated that failure to account for stroke lesions when measuring WML volume could increase significantly both median baseline and follow-up WML volume by about 20%…”
BackgroundMethodInfluentialSelf-citation
Cited by
Wardlaw, J. M., Smith, E. E., Biessels, G. J., Cordonnier, C., Fazekas, F., Frayne, R., Lindley, R. I., O'Brien, J. T., Barkhof, F., Benavente, O. R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70124-8 · Cited by 5,544
Self-citationWhat are White Matter Hyperintensities Made of?: Relevance to Vascular Cognitive Impairment
Wardlaw, J. M., Valdés Hernández, M. C., & Muñoz‐Maniega, S. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001140 · Cited by 902
Self-citationGuerrero, R., Qin, C., Oktay, O., Bowles, C., Chen, L., Joules, R., Wolz, R., Valdés-Hernández, M. C., Dickie, D. A., Wardlaw, J., et al. (2018) · NeuroImage: Clinical · doi:10.1016/j.nicl.2017.12.022 · Cited by 223
Self-citationVascular risk factors, large-artery atheroma, and brain white matter hyperintensities
Wardlaw, J. M., Allerhand, M., Doubal, F. N., Valdes Hernandez, M., Morris, Z., Gow, A. J., Bastin, M., Starr, J. M., Dennis, M. S., & Deary, I. J. (2014) · Neurology · doi:10.1212/wnl.0000000000000312 · Cited by 213
Self-citationWhite matter hyperintensity reduction and outcomes after minor stroke
Wardlaw, J. M., Chappell, F. M., Valdés Hernández, M. D. C., Makin, S. D. J., Staals, J., Shuler, K., Thrippleton, M. J., Armitage, P. A., Muñoz-Maniega, S., Heye, A. K., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004328 · Cited by 154
Self-citation
Metadata
- Authors
- Wang, X., Valdés Hernández, M. C., Doubal, F., Chappell, F. M., & Wardlaw, J. M.
- Affiliations
- University of Edinburgh (GB)
- Corresponding author
- Wardlaw, Joanna M.
- Venue
- Cerebrovascular Diseases
- Publisher
- S. Karger AG
- Published
- 2012
- Volume
- 34
- Issue
- 5-6
- Pages
- 336-342
- ISSN
- 1015-9770 (ISSN-L)
- 1421-9786
- PMC
- PMC3566554
- OpenAlex
- W2167519590
- Cited by
- 31
- References
- 17
- Citations by year
- 2025: 2 · 2024: 1 · 2022: 2 · 2019: 3 · 2018: 2 · 2017: 7 · 2016: 4 · 2015: 7 · 2014: 1 · 2013: 2
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/3.0/ (vor)
- creativecommons.org/licenses/by/3.0/ (tdm)
- Locations
- Cerebrovascular Diseases (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (075611)
- Mrs Gladys Row Fogo Charitable Trust
- Brain Research Imaging Centre, University of Edinburgh
- Topics
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- white matter lesions, brain atrophy, lacunes, stroke lesions, cerebrospinal fluid, longitudinal progression, lacunar stroke, minor ischaemic stroke, biomarkers, older adults, longitudinal MRI follow-up, white matter hyperintensities
- MeSH terms
- Aged, Aged, 80 and over, Atrophy, Cerebral Infarction, Dementia, Follow-Up Studies, Humans, Image Processing, Computer-Assisted, Longitudinal Studies, Magnetic Resonance Imaging, Disease Progression, Neurodegenerative Diseases, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: How Much Do Focal Infarcts Distort White Matter Lesions and Global Cerebral Atrophy Measures? https://app.cochat.ai/papers/10.1159/000343226
- The paper
- Wang, X., Valdés Hernández, M. C., Doubal, F., Chappell, F. M., & Wardlaw, J. M. (2012). How Much Do Focal Infarcts Distort White Matter Lesions and Global Cerebral Atrophy Measures? Cerebrovascular Diseases. https://doi.org/10.1159/000343226
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.